Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia. (Q50283810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Olli Ruuskanen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

14 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1784-1786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24633687%20AND%20SRC:MED&resulttype=core&format=json

New aspects on human rhinovirus infections.

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Viruses exacerbating chronic pulmonary disease: the role of immune modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Chronic rhinovirus infection in an adult with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU169

Chronic rhinoviral infection in lung transplant recipients.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24633687

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24633687

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of type I interferon responses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24633687